PharmGen Science Inc
KRX:004720

Watchlist Manager
PharmGen Science Inc Logo
PharmGen Science Inc
KRX:004720
Watchlist
Price: 4 230 KRW -0.7% Market Closed
Market Cap: ₩79.6B

Profitability Summary

PharmGen Science Inc's profitability score is hidden . We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Sign Up to see
Profitability Score
Sign In
Sign Up

Margins

Earnings Waterfall
PharmGen Science Inc

Margins Comparison
PharmGen Science Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
KR
PharmGen Science Inc
KRX:004720
80B KRW
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
PharmGen Science Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
KR
PharmGen Science Inc
KRX:004720
80B KRW
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
992.9B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
541.8B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
278.2B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
216.3B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
223.2B CHF
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.1B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151B USD
Loading...
Loading...
Loading...
Loading...
FR
Sanofi SA
PAR:SAN
97.1B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
PharmGen Science Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate